^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Ampulla of Vater Carcinoma |
| Drug: | Imfinzi (durvalumab) (PD-L1 inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
04/27/2023
Excerpt:
Ampullary Adenocarcinoma...Good PS….Pancreatobiliary/Mixed Type….Gemcitabine + cisplatin + durvalumab
Secondary therapy:
cisplatin + gemcitabine
